n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, July 28th, 2016

The QualityStocks
Daily Stock List

graphic
graphic

Yew Bio-Pharm Group, Inc. (YEWB)

Greenbackers reported on Yew Bio-Pharm Group, Inc. (YEWB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Yew Bio-Pharm Group, Inc., via its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM), handicraft products made from yew timber, and yew candle made with yew essence oil in China. The Company’s shares trade on the OTC Bulletin Board.

Formed in 1996, Yew Bio-Pharm has its headquarters in Xiangfang District, Harbin City, Heilongjiang Province, China. In addition, Yew Bio-Pharm has established a division to concentrate on organic foods and dietary supplements with the goal of developing new business opportunities in related industries.

Raw material from the species of yew tree that Yew Bio-Pharm grows contains taxol, and TCM containing yew raw materials has received approval as a traditional Chinese medicine (TCM) in China for the secondary treatment of certain cancers. The Company grows Japanese yew trees (also known in China as Northeast yew trees), taxus cuspidata, on mountain hillsides near Harbin. It cultivates them in four nurseries it operates close to Harbin.

Yew Bio-Pharm uses a patented, accelerated growth technology to hasten the growth and maturity and commercialization of yew trees. In addition, it operates production facilities to manufacture yew handicrafts.

The Company’s patented Asexual Reproduction Method speeds up the commercial viability of a yew tree. Thus, a yew tree can be used for commercialization starting in approximately three years, in comparison to greater than 50 years for naturally grown yew trees.

Through this method, Yew Bio-Pharm can more than replenish the number of yew trees it cultivates and puts into production. The patented Asexual Reproduction Method was developed by Yew Bio-Pharm’s Founder and President, Mr. Zhiguo Wang. The Patent is valid through September 29, 2030.

Recently, Yew Bio-Pharm Group reported financial results for the three months ended March 31, 2016. Total revenues for Q1 of 2016 increased 226 percent to $8.6 million from $2.6 million the year prior. For the 2016 Q1, gross profit was $1.4 million, or 16.2 percent of total revenues, versus $1.5 million, or 55.7 percent of total revenues for the comparable 2015 quarter.

Operating expenses decreased 33 percent to $315,900 for the quarter ended March 31, 2016, from $472,066 in the prior year quarter. Net income for the three months ended March 31, 2016 grew 9.6 percent to $1.1 million from $958,390 in the same quarter last year because of the decreases in operating expenses.

Yew Bio-Pharm Group, Inc. (YEWB), closed Thursday's trading session at $0.096, up 6.67%, on 38,900 volume with 5 trades. The average volume for the last 60 days is 19,221 and the stock's 52-week low/high is $0.027/$0.22.

Bio-AMD, Inc. (BIAD)

Today we are reporting on Bio-AMD, Inc. (BIAD), here at the QualityStocks Daily Newsletter.

OTCQB-listed, Bio-AMD, Inc. has two majority owned United Kingdom (UK) subsidiaries. One is Bio-AMD Ltd., which is a technology developer for medical diagnostic devices. The other is WOCU Ltd., the owner of the WOCU®, an international currency data reference source for application in financial markets. The Company has positioned itself as a top innovator in the field of reader technology development. Bio-AMD has its corporate head office in Cheshire, England.

Bio-AMD is the 63 percent owner of Bio-AMD Ltd., a technology development company positioned in the fast emerging Point of Care (PoC) medical diagnostics sector. PoC medical diagnostics is a multi-billion-dollar global market.

Currently, Bio-AMD has three proprietary technology platforms. These technology platforms include a disposable micro-fluidic test strip that has been adapted to measure prothrombin time (PT)/INR via a PoC blood coagulation monitoring device (COAG) enabling patient based, anticoagulant drug therapy monitoring.  

In addition, Bio-AMD’s platforms include a Digital Strip Reader (DSR). It can read a wide array of lateral flow based immunoassay diagnostic test strips already in the PoC market. These include, but are not limited to, cardiac markers, infectious diseases, drugs of abuse, and female wellbeing (pregnancy/ovulation testing) to provide semi-quantitative results.

The DSR technology platform utilizes a patented, proprietary method for reading and quantifying traditional chromatography based, nitro-cellulose, lateral-flow immunoassay tests, centered on what the Company believes to be an innovative optical sensor arrangement. The DSR consists of a proprietary design incorporating sensors, diagnostics, as well as display and power management capabilities.

Bio-AMD is also developing a fully quantitative Magnetic Immunoassay Detection System (MIDS). Its expectation is that this will have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, which can interpret results on a quantitative basis.

Last month, Bio-AMD, Inc. and Bio-AMD UK Holdings Ltd., its majority owned medical devices subsidiary provided an update on its MIDS project and a restructuring of the Company’s medical device subsidiary operations. Regarding restructuring, Bio-AMD, with the agreement and support of its key scientific team, restructured its UK medical device business from its existing UK holding company into a new UK holding company (UKH).

Bio-AMD also announced that it entered into a joint venture (JV) with a nano-cap medical detection technology company to affect the first stage of the development of Bio-AMD’s MIDS universal immunoassay device - the MIDS Project. Under the terms of the JV, Bio-AMD was due to receive a payment of $130,000 by July 1, 2016, with four subsequent bi-monthly payments, beginning in September 2016, for a total aggregate amount of £450,500 (approximately $650,000). The MIDS Project will be carried out by a new JV vehicle, MIDS Medical Limited (MML), a newly-formed subsidiary of UKH.

Bio-AMD, Inc. (BIAD), closed Thursday's trading session at $0.046, up 64.29%, on 565 volume with 3 trades. The average volume for the last 60 days is 20,200 and the stock's 52-week low/high is $0.02/$0.1448.

5BARz International, Inc. (BARZ)

Stock Commander, AllPennyStocks, and OTC Markets Group reported on 5BARz International, Inc. (BARZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, 5BARz International, Inc. is a technology leader in the cellular network extender industry. It focuses on the global commercialization of a patented product technology branded under the name 5BARz™.  5BARz™ is a cellular network infrastructure device for use in the small office, home, or for when users are mobile. 5BARz™ represents an important solution for cellular network operators in providing clear, high quality signal for their subscribers with an increasing need for high quality connectivity.  5BARz International is headquartered in San Diego, California.

The Company’s products include the 5BARz Network Extender and the 5BARz Road Warrior.  5BARz™ incorporates a patented technology to create a highly engineered, single-piece, plug 'n play unit. It strengthens weak cellular signals to deliver high quality signals for voice, data, and video reception on cell phones and other cellular equipped devices.

5BARz International’s innovative product is the 5BARz Network Extender™. The 5Barz Network Extender™ is a “carrier grade” cellular network infrastructure device. It can be remotely managed from each carrier’s Network Operation Center.

The 5Barz Network Extender™ includes patented technologies, including bringing together the send and receive antenna into a single form factor, automatically cancels echo or “noise cancellation”, supports multiple bands and all frequencies around the world, and automatically balances power management to avoid any interference with the macro network. Furthermore, it can support up to ten simultaneous users at a time.

5BARz established a subsidiary Company, 5BARz India Private Ltd., in Bangalore, India. 5BARz India is a wholly-owned subsidiary of 5BARz. It is licensed the exclusive rights to market and distribute all of 5BARz products across India in perpetuity. 5BARz India has begun commercial rollout of the 5BARz™ Network Extender in India.

This month, 5BARz International said that, via its subsidiary 5BARz India, it continues to make major progress into the Indian market as it commercializes its network extender business in the nation. In Q1 2016, 5BARz India received an initial purchase order for the 5BARz network extender from a tier-one telecommunications company in India. Moreover, in Q2 2016 it received a follow-on purchase order from that same company.

5BARz India recently received multiple purchase orders from a second, tier-one telecommunications company in India. 5BARz India’s expectation is to have sales revenue of around $2 million during Q3 and Q4 2016 combined.

5BARz International, Inc. (BARZ), closed Thursday's trading session at $0.084, up 8.27%, on 372,900 volume with 17 trades. The average volume for the last 60 days is 510,204 and the stock's 52-week low/high is $0.0451/$0.20.

Two Rivers Water & Farming Company (TURV)

Jet-Life Penny Stocks, Stock News Now, Cannabis Financial Network News, SmallCapVoice, TopPennyStockMovers, IRGnews Alert, and Stock Guru reported on Two Rivers Water & Farming Company (TURV), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the southwestern U.S. The Company assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that produce higher revenues and better profit margins. Two Rivers Water & Farming is headquartered in Denver, Colorado. Its majority-owned subsidiary is GrowCo, Inc.

Two Rivers’ current farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado. The Company is providing greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Additionally, Two Rivers develops Metropolitan Districts to serve underserved communities in rural regions in which Two Rivers' farmland and water rights are situated.

Concerning Farming, Two Rivers’ produce sells to national accounts by way of its wholly-owned subsidiary Dionisio Farms & Produce. Regarding Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, obtained in connection with its purchases of irrigated farmland. Its water rights give it the ability to divert stream flow, operate storage reservoirs, pump ground water and augment depletions of water taken out of priority. Moreover, Two Rivers pumps water from the Arkansas River alluvium in addition to stream flow that it diverts from the Arkansas River and its tributaries.

The Company’s majority-owned subsidiary, GrowCo, was created in May 2014 to build greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, via its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to build state-of-the-art greenhouse facilities for licensed marijuana growers. Growers leasing a GrowCo greenhouse can expect to grow a more natural premium product using the sun's energy and efficient water-based cooling systems rather than depending solely on costly artificial lights and air conditioning systems. GrowCo centers on the construction of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

In May of this year, Two Rivers announced it completed a settlement agreement with the State of Colorado for the development of the Cucharas dam and reservoir. With this settlement, Two Rivers would temporarily lower the existing dam structure and build a new, more stable permanent dam. As part of the settlement discussions, Two Rivers discussed with the State the possibility of using the Two Rivers' Huerfano Cucharas Irrigation Company's (HCIC) reservoir and canal system, including the Orlando reservoir and canal, to cooperate with other water users in the creation of a new basin-wide augmentation plan. Two Rivers owns 95 percent of HCIC and 100 percent of the Orlando reservoir and canal.

Yesterday, GrowCo announced it entered into a series of agreements to recapitalize GrowCo, re-lease its greenhouse facilities, and formalize the ownership interest and relationship that Two Rivers has with GrowCo moving ahead.

Two Rivers Water & Farming Company (TURV), closed Thursday's trading session at $0.22, up 22.22%, on 103,876 volume with 16 trades. The average volume for the last 60 days is 27,274 and the stock's 52-week low/high is $0.12/$0.95.

Acorn Energy, Inc. (ACFN)

Marketbeat.com, MegaPennyStocks, Catalyst IR, Wall Street Resources, Wealthpire, Inc., SmarTrend Newsletters, and Hit and Run Candle Sticks reported on Acorn Energy, Inc. (ACFN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Acorn Energy, Inc. is a holding company that has two portfolio businesses: OmniMetrix and DSIT. Furthermore, Acorn Energy has started the process to liquidate the assets of its GridSense® subsidiary. Acorn Energy is based in Wilmington, Delaware and the Company’s shares trade on the OTC Markets Group’s OTCQB.

Acorn’s OmniMetrix™ remotely monitors emergency back-up power generation systems to increase their reliability. OmniMetrix™ is the leader and pioneer in M2M wireless remote monitoring, control and diagnostics for pipelines and critical equipment.  

OmniMetrix is a solution for making critical systems more reliable. The Company is a solution for pipelines and critical facilities worldwide. This includes cell towers, medical facilities, data centers, public transportation systems, and federal, state and municipal government facilities.

Acorn Energy’s DSIT Solutions Ltd. provides security solutions from underwater threats to naval and marine based energy assets. DSIT specializes in the science of sonar and underwater acoustics. It develops advanced Acoustic Intelligence (ACINT) measurement and analysis applications. The Company’s Shield™ family of Underwater Security Systems provides automatic Diver Detection Sonars for protection of valuable coastal and offshore sites.

Acorn Energy announced this past April that it completed the earlier announced sale of almost 50 percent of its 79 percent fully diluted interest in its DSIT Solutions underwater sonar and acoustic detection systems business to Israel-based Rafael Advanced Defense Systems Ltd., realizing gross proceeds of approximately $4.9 million, excluding escrow and taxes.

GridSense® provides monitoring for all critical points along the electricity delivery system. It develops pioneering, practical and cost effective monitoring solutions for the power sector. GridSense® provides technology and services, which help its customers address the limitations of an old and aging infrastructure. Acorn Energy’s CEO, Mr. Jan Loeb, said that the liquidation process is the most immediate path to stem the operating losses and cash drain of the GridSense business.

Last month, DSIT Solutions, the 41.2 percent-held equity investment of Acorn Energy, announced that it received a new $7.1 million order for its Blackfish Hull Mounted Sonar (HMS) systems. These are to be delivered over a two-year period. The Blackfish is an advanced, medium-frequency Hull Mounted Sonar. The design of it is for littoral (near shore) and also deep-water Anti-Submarine Warfare (ASW) operations.

Earlier this month, Acorn Energy announced it completed the sale of the assets of its GridSense® subsidiary to Franklin Electric Co., Inc. (FELE) for a gross sales price of $1 million. The asset sale follows Acorn's April 21, 2016 announcement of its intention to liquidate its GridSense business.

Acorn Energy, Inc. (ACFN), closed Thursday's trading session at $0.215, down 10.42%, on 70,100 volume with 19 trades. The average volume for the last 60 days is 28,451 and the stock's 52-week low/high is $0.071/$0.49.

graphic

The QualityStocks
Company Corner

graphic
graphic

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $1.99, up 3.11%, on 7,895 volume with 35 trades. The stock’s average daily volume over the past 60 days is 5,098, and its 52-week low/high is $1.25/$6.95.

International Stem Cell Corp. today announced that the first patient in the previously announced Phase I clinical trial has undergone a successful intracranial transplant of ISC-hpNSC as a treatment under investigation for Parkinson’s Disease (PD). The operation took place at The Royal Melbourne Hospital in Australia. The phase I clinical trial will evaluate the safety and tolerability of ISCO’s human parthenogenetic stem cell therapy, which uses cells that are cGMP and ethically manufactured through the company’s proprietary technology.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC

International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.005, up 25.00%, on 23,285,020 volume with 202 trades. The stock’s average daily volume over the past 60 days is 2,429,258 and its 52-week low/high is $0.003/$0.212.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Issues Open Letter to Shareholders

Dominovas Energy Announces Plan to Restructure and Consolidate Outstanding Debt

Dominovas Energy Welcomes Project Finance Team

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0126, up 26.00%, on 5,017,690 volume with 111 trades. The stock’s average daily volume over the past 60 days is 742,881, and its 52-week low/high is $0.0041/$0.018.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint, Inc. Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist

A New Audio Interview with Greg Lambrecht, CEO of SinglePoint Inc., is Now at SmallCapVoice.com

SinglePoint, Inc. Announces Senate Approval of Daily Fantasy Sports Bill; Predicts DraftFury to Become Top Player in Multi-Billion Dollar DFS Market

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.9316, up 3.51%, on 6,313 volume with 13 trades. The stock’s average daily volume over the past 60 days is 4,583, and its 52-week low/high is $0.63/$1.06.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet's Company Now Licensing Polymer Bonded Pet Bowl Patent

OurPet's Company Sponsors 65th Annual BetterInvesting National Convention

OurPet’s Company Reports Record 2016 First Quarter Results

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0283, up 25.78%, on 94,878 volume with 12 trades. The stock’s average daily volume over the past 60 days is 9,769, and its 52-week low/high is $0.0201/$750.00.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Cherubim Interests, Inc. Signs LOI to Construct Single-Family Residential Rental Properties

Cherubim Interests, Inc. Announces Letter to Shareholders

Cherubim Interests, Inc. Acquires Victura Roofing and Cherubim Builders Group Oklahoma

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Profitable Trader Authority
(MERR)

2.

QualityStocks
(BIAD)

3.

BUYINS.NET
(EVOK)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251